.Innovent Biologics has helped make the case that its checkpoint inhibitor-cytokine fusion protein p...
.A phase 3 test of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate ...
.5 months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotech h...
.Ascendis Pharma has actually emerged as a potential hazard to BioMarin's Voxzogo, reporting period ...
.Though Alkeus Pharmaceuticals' oral eye disease asset neglected to considerably minimize geographic...
.Along with a triad of biotechs reaching the Nasdaq on Friday, it was quick and easy to skip a small...
.Invulnerable checkpoint inhibitors are the superheroes of cancer treatment. Medications like Bristo...
.Accept to recently's Chutes & Ladders, our summary of notable leadership hirings, firings and re...
.Regeneron is actually back along with long-term follow-up for its LAG-3 inhibitor and PD-1 preventi...
.AstraZeneca has actually shared a very early consider the efficiency of its internal antibody-drug ...
.After declaring a stage 3 launch based on beneficial midstage outcomes, iTeos and GSK are finally d...
.The FDA ought to be actually extra available and collective to unleash a surge in approvals of unco...
.It is actually an uncommonly hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara T...
.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 trial, however the b...
.Neurocrine Biosciences' mental illness course pivot has actually neglected. The biotech was actuall...
.Sanofi has actually created a late access to the radioligand event, paying out 100 thousand europea...
.After F2G's initial try to acquire a brand-new course of antifungal to market was wrecked due to th...
.Moderna has actually promised to reduce R&D costs by $1.1 billion by 2027. The decision to shrin...
.Merely 4 months after Sanofi bet $80 million in ahead of time money on Key Rehabs' losmapimod, the ...
.Cancer cells company Oncternal Therapies is folding all its clinical tests and also laying off staf...